S Broder

648 total citations
13 papers, 531 citations indexed

About

S Broder is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, S Broder has authored 13 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in S Broder's work include T-cell and Retrovirus Studies (5 papers), HIV/AIDS drug development and treatment (4 papers) and Biochemical and Molecular Research (3 papers). S Broder is often cited by papers focused on T-cell and Retrovirus Studies (5 papers), HIV/AIDS drug development and treatment (4 papers) and Biochemical and Molecular Research (3 papers). S Broder collaborates with scholars based in United States, Malaysia and Italy. S Broder's co-authors include D G Johns, Erik De Clercq, Jan Balzarini, Piet Herdewijn, Maha Dalal, Kurt Hirschhorn, David A. Cooney, Robert Yarchoan, Gurpreet S. Ahluwalia and Arnold Fridland and has published in prestigious journals such as Blood, Molecular Pharmacology and Scientific American.

In The Last Decade

S Broder

13 papers receiving 492 citations

Peers

S Broder
R Carlisle United States
William B. Mahony United States
Julie Q. Hang United States
Samuel Broder United States
J L Martin United States
C U Lambe United States
Geneviève Laflamme United States
Edward Littler United Kingdom
R Carlisle United States
S Broder
Citations per year, relative to S Broder S Broder (= 1×) peers R Carlisle

Countries citing papers authored by S Broder

Since Specialization
Citations

This map shows the geographic impact of S Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Broder more than expected).

Fields of papers citing papers by S Broder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Broder. The network helps show where S Broder may publish in the future.

Co-authorship network of co-authors of S Broder

This figure shows the co-authorship network connecting the top 25 collaborators of S Broder. A scholar is included among the top collaborators of S Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Broder. S Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ahluwalia, Gurpreet S., David A. Cooney, Neil R. Hartman, et al.. (1993). Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.. Drug Metabolism and Disposition. 21(2). 369–376. 33 indexed citations
2.
Hartman, Neil R., Gurpreet S. Ahluwalia, David A. Cooney, et al.. (1991). Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.. Molecular Pharmacology. 40(1). 118–124. 44 indexed citations
3.
Ahluwalia, Gurpreet S., David A. Cooney, Arnold Fridland, et al.. (1990). 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.. Molecular Pharmacology. 37(4). 590–596. 36 indexed citations
4.
Yarchoan, Robert, H Mitsuya, & S Broder. (1988). AIDS Therapies. Scientific American. 259(4). 110–119. 28 indexed citations
5.
Kelley, James A., Charles L. Litterst, David T. Vistica, et al.. (1987). The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.. Drug Metabolism and Disposition. 15(5). 595–601. 71 indexed citations
6.
Balzarini, Jan, Maha Dalal, Piet Herdewijn, et al.. (1987). The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.. Molecular Pharmacology. 32(1). 162–167. 212 indexed citations
7.
Mitsuya, Hiroaki, Sachiko Matsushita, Robert Yarchoan, & S Broder. (1984). Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.. PubMed. 15. 277–88. 1 indexed citations
8.
Ta, Waldmann, et al.. (1983). Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks.. PubMed. 42(8). 2498–503. 2 indexed citations
9.
Broder, S, Takeo UCHIYAMA, & Waldmann Ta. (1979). Neoplasms of immunoregulatory cells.. PubMed. 72(4 Suppl). 724–31. 16 indexed citations
10.
Levene, Ralph Z., P. L. Workman, S Broder, & Kurt Hirschhorn. (1970). Heritability of Ocular Pressure. Archives of Ophthalmology. 84(6). 730–734. 26 indexed citations
11.
Broder, S, Philip R. Glade, & Kurt Hirschhorn. (1970). Brief Report: Establishment of Long-term Lines from Small Aliquots of Normal Lymphocytes. Blood. 35(4). 539–542. 20 indexed citations
12.
Flier, Jeffrey S., Philip R. Glade, S Broder, & Kurt Hirschhorn. (1970). Lymphocyte stimulation by allogeneic and autochthonous cultured lymphoid cells. Cellular Immunology. 1(6). 596–602. 21 indexed citations
13.
Bernoco, D, et al.. (1969). Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro.. PubMed. 54(11). 795–812. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026